Oral Tirzepatide

Oral Tirzepatide is an experimental form of the same powerful medication found in the injectable version, offering the same dual-hormone targeting in a convenient daily pill. It activates both GLP-1 and GIP receptors, helping regulate blood sugar and reduce appetite.

Though still under review for full approval, oral tirzepatide is part of a new wave of advanced treatments aimed at simplifying diabetes and weight management—especially for people who prefer not to use needles.

This medication is used for managing type 2 diabetes and may be prescribed off-label for weight loss support.

• Type 2 diabetes control
• Weight loss and appetite management
• Reducing post-meal blood sugar spikes
• Supporting metabolic health
• Improving insulin sensitivity

Common side effects of oral tirzepatide

• Nausea
• Diarrhea
• Bloating
• Abdominal pain
• Fatigue
• Dizziness
• Loss of appetite
• Constipation

Oral Tirzepatide is taken as a daily pill, currently available in limited-release programs. It is typically started at a low dose and increased based on tolerance and treatment goals.

Exact strengths may vary based on clinical program access and provider discretion.

Oral Tirzepatide should be taken once daily, preferably at the same time each day. It should be taken on an empty stomach with a small amount of water, followed by a short waiting period before eating.

Tips:

• Take on an empty stomach
• Wait at least 30 minutes before eating
• Use same time daily
• Swallow whole—don’t crush or chew
• Follow provider’s titration instructions

As with the injectable version, oral tirzepatide should not be used by individuals with a personal or family history of medullary thyroid cancer or MEN 2. These conditions may increase the risk of thyroid complications.

Additionally, anyone with severe digestive disorders, a history of pancreatitis, or allergies to similar medications should consult with their 24hrDoc provider before starting treatment.